Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous Condition
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: pyroxamide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]